Recombinant LAG3 anticorps (AA 500-525)

N° du produit ABIN7454036

Cet anticorps anti-LAG3 Monoclonal Lapin (Clone BLR027F) (ABIN7454036) détecte spécifiquement LAG3 dans WB, IHC, ICC, IP, FACS, IF (p) et mIF. L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour Recombinant LAG3 anticorps (AA 500-525) (ABIN7454036)

Antigène: LAG3 (Lymphocyte-Activation Gene 3 (LAG3))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp LAG3 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP), Flow Cytometry (FACS), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Multiplex Immunofluorescence (mIF)

Clone: BLR027F

Détail du produit anti-LAG3 anticorps

Épitope: AA 500-525

Fonction: Rabbit anti-LAG3 Recombinant Monoclonal Antibody [BLR027F] - BSA-Free

Purification: Purified

Immunogène: between AA 500 and 525 (C-term)

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1000 μg/mL

Buffer: Borate Buffered Saline (BBS) pH 8.2 with 0.09 % Sodium Azide, BSA-Free

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: 2 - 8 °C

Date de péremption: 12 months

Détails sur LAG3

Antigène: LAG3 (Lymphocyte-Activation Gene 3 (LAG3))

Autre désignation: LAG3

Sujet: Lymphocyte-activation protein 3 belongs to Ig superfamily and contains 4 extracellular Ig-like domains. The LAG3 gene contains 8 exons. The sequence data, exon/intron organization, and chromosomal localization all indicate a close relationship of LAG3 to CD4 [taken from NCBI Entrez Gene (Gene ID: 3902)]

ID gène: 3902

UniProt: P18627

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints